Pompe Disease Market Share

Statistics for the 2023 & 2024 Pompe Disease market share, created by Mordor Intelligence™ Industry Reports. Pompe Disease share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Genetic Disorder Drugs Research Pompe Disease Treatment Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Pompe Disease Industry

The Pompe disease market is moderately competitive and consists of several major players. Some companies currently dominating the market are Amicus Therapeutics, EpiVax, Inc., Oxyrane, Sanofi, Astellas Pharma, and Genethon, among others.

Pompe Disease Market Leaders

  1. Amicus Therapeutics

  2. EpiVax, Inc

  3. Sanofi Inc.

  4. AVROBIO, Inc.

  5. Astellas Pharma

*Disclaimer: Major Players sorted in no particular order

Pompe Disease Market Concentration

Pompe Disease Treatment Market Report Snapshots

Pompe Disease Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)